 | • レポートコード：MRC2012A5195 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、IVIGの世界市場を広く調査・分析し、今後の市場展望をまとめております。IVIGの種類別市場規模（注射、凍結乾燥粉末）、用途別市場規模（多発性硬化症（MS）、重症筋無力症（MG）、多巣性運動ニューロパチー（MMN）、多巣性後天性感覚・運動ニューロパシー（MADSAM）、皮膚筋炎、多巣性運動ニューロシス）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Green Cross、Taibang Bio、RAAS、BSV、Tiantan Bio、Hualan Bio、SIBP、Kangbao Bio、YUAN DA SHUYANG、Weiguang Bio、Xinxing Medicine、TONROL、Weilun Bio、RUIDE Bio、RUIDE Bio、WIBP、BOYA Bio、 ・地域別グローバル市場分析 2015年-2020年 ・IVIGの北米市場（アメリカ、カナダ、メキシコ） ・IVIGのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・IVIGのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・IVIGの南米市場（ブラジル、アルゼンチン） ・IVIGの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：注射、凍結乾燥粉末 ・用途別分析：多発性硬化症（MS）、重症筋無力症（MG）、多巣性運動ニューロパチー（MMN）、多巣性後天性感覚・運動ニューロパシー（MADSAM）、皮膚筋炎、多巣性運動ニューロシス ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global IVIG market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The IVIG market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
IVIG market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, IVIG market has been segmented into
Injection
Lyophilized Powder
By Application, IVIG has been segmented into:
Multiple Sclerosis (MS)
Myasthenia Gravis (MG)
Multifocal Motor Neuropathy (MMN)
Multifocal Acquired Sensory and Motor Neuropathy (MADSAM)
Dermatomyositis
Polymyositis
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global IVIG market presented in the report. This section sheds light on the sales growth of different regional and country-level IVIG markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global IVIG market.
The report offers in-depth assessment of the growth and other aspects of the IVIG market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and IVIG Market Share Analysis
IVIG competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, IVIG sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the IVIG sales, revenue and market share for each player covered in this report.
The major players covered in IVIG are:
Green Cross
Taibang Bio
RAAS
BSV
Tiantan Bio
Hualan Bio
SIBP
Kangbao Bio
YUAN DA SHUYANG
Weiguang Bio
Xinxing Medicine
TONROL
Weilun Bio
RUIDE Bio
RUIDE Bio
WIBP
BOYA Bio
Among other players domestic and global, IVIG market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe IVIG product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of IVIG, with price, sales, revenue and global market share of IVIG in 2018 and 2019.
Chapter 3, the IVIG competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the IVIG breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, IVIG market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe IVIG sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 IVIG Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global IVIG Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Injection
1.2.3 Lyophilized Powder
1.3 Market Analysis by Application
1.3.1 Overview: Global IVIG Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Multiple Sclerosis (MS)
1.3.3 Myasthenia Gravis (MG)
1.3.4 Multifocal Motor Neuropathy (MMN)
1.3.5 Multifocal Acquired Sensory and Motor Neuropathy (MADSAM)
1.3.6 Dermatomyositis
1.3.7 Polymyositis
1.4 Overview of Global IVIG Market
1.4.1 Global IVIG Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Green Cross
2.1.1 Green Cross Details
2.1.2 Green Cross Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Green Cross SWOT Analysis
2.1.4 Green Cross Product and Services
2.1.5 Green Cross IVIG Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Taibang Bio
2.2.1 Taibang Bio Details
2.2.2 Taibang Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Taibang Bio SWOT Analysis
2.2.4 Taibang Bio Product and Services
2.2.5 Taibang Bio IVIG Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 RAAS
2.3.1 RAAS Details
2.3.2 RAAS Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 RAAS SWOT Analysis
2.3.4 RAAS Product and Services
2.3.5 RAAS IVIG Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 BSV
2.4.1 BSV Details
2.4.2 BSV Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 BSV SWOT Analysis
2.4.4 BSV Product and Services
2.4.5 BSV IVIG Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Tiantan Bio
2.5.1 Tiantan Bio Details
2.5.2 Tiantan Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Tiantan Bio SWOT Analysis
2.5.4 Tiantan Bio Product and Services
2.5.5 Tiantan Bio IVIG Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Hualan Bio
2.6.1 Hualan Bio Details
2.6.2 Hualan Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Hualan Bio SWOT Analysis
2.6.4 Hualan Bio Product and Services
2.6.5 Hualan Bio IVIG Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 SIBP
2.7.1 SIBP Details
2.7.2 SIBP Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 SIBP SWOT Analysis
2.7.4 SIBP Product and Services
2.7.5 SIBP IVIG Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Kangbao Bio
2.8.1 Kangbao Bio Details
2.8.2 Kangbao Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Kangbao Bio SWOT Analysis
2.8.4 Kangbao Bio Product and Services
2.8.5 Kangbao Bio IVIG Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 YUAN DA SHUYANG
2.9.1 YUAN DA SHUYANG Details
2.9.2 YUAN DA SHUYANG Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 YUAN DA SHUYANG SWOT Analysis
2.9.4 YUAN DA SHUYANG Product and Services
2.9.5 YUAN DA SHUYANG IVIG Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Weiguang Bio
2.10.1 Weiguang Bio Details
2.10.2 Weiguang Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Weiguang Bio SWOT Analysis
2.10.4 Weiguang Bio Product and Services
2.10.5 Weiguang Bio IVIG Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Xinxing Medicine
2.11.1 Xinxing Medicine Details
2.11.2 Xinxing Medicine Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Xinxing Medicine SWOT Analysis
2.11.4 Xinxing Medicine Product and Services
2.11.5 Xinxing Medicine IVIG Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 TONROL
2.12.1 TONROL Details
2.12.2 TONROL Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 TONROL SWOT Analysis
2.12.4 TONROL Product and Services
2.12.5 TONROL IVIG Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Weilun Bio
2.13.1 Weilun Bio Details
2.13.2 Weilun Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Weilun Bio SWOT Analysis
2.13.4 Weilun Bio Product and Services
2.13.5 Weilun Bio IVIG Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 RUIDE Bio
2.14.1 RUIDE Bio Details
2.14.2 RUIDE Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 RUIDE Bio SWOT Analysis
2.14.4 RUIDE Bio Product and Services
2.14.5 RUIDE Bio IVIG Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 RUIDE Bio
2.15.1 RUIDE Bio Details
2.15.2 RUIDE Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 RUIDE Bio SWOT Analysis
2.15.4 RUIDE Bio Product and Services
2.15.5 RUIDE Bio IVIG Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 WIBP
2.16.1 WIBP Details
2.16.2 WIBP Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 WIBP SWOT Analysis
2.16.4 WIBP Product and Services
2.16.5 WIBP IVIG Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 BOYA Bio
2.17.1 BOYA Bio Details
2.17.2 BOYA Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 BOYA Bio SWOT Analysis
2.17.4 BOYA Bio Product and Services
2.17.5 BOYA Bio IVIG Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global IVIG Sales and Market Share by Manufacturer (2018-2019)
3.2 Global IVIG Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 IVIG Manufacturer Market Share in 2019
3.3.2 Top 6 IVIG Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global IVIG Sales, Revenue and Market Share by Regions
4.1.1 Global IVIG Sales and Market Share by Regions (2015-2020)
4.1.2 Global IVIG Revenue and Market Share by Regions (2015-2020)
4.2 North America IVIG Sales and Growth Rate (2015-2020)
4.3 Europe IVIG Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific IVIG Sales and Growth Rate (2015-2020)
4.5 South America IVIG Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa IVIG Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America IVIG Sales, Revenue and Market Share by Country
5.1.1 North America IVIG Sales and Market Share by Country (2015-2020)
5.1.2 North America IVIG Revenue and Market Share by Country (2015-2020)
5.2 United States IVIG Sales and Growth Rate (2015-2020)
5.3 Canada IVIG Sales and Growth Rate (2015-2020)
5.4 Mexico IVIG Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe IVIG Sales, Revenue and Market Share by Country
6.1.1 Europe IVIG Sales and Market Share by Country (2015-2020)
6.1.2 Europe IVIG Revenue and Market Share by Country (2015-2020)
6.2 Germany IVIG Sales and Growth Rate (2015-2020)
6.3 UK IVIG Sales and Growth Rate (2015-2020)
6.4 France IVIG Sales and Growth Rate (2015-2020)
6.5 Russia IVIG Sales and Growth Rate (2015-2020)
6.6 Italy IVIG Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific IVIG Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific IVIG Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific IVIG Revenue and Market Share by Regions (2015-2020)
7.2 China IVIG Sales and Growth Rate (2015-2020)
7.3 Japan IVIG Sales and Growth Rate (2015-2020)
7.4 Korea IVIG Sales and Growth Rate (2015-2020)
7.5 India IVIG Sales and Growth Rate (2015-2020)
7.6 Southeast Asia IVIG Sales and Growth Rate (2015-2020)
7.7 Australia IVIG Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America IVIG Sales, Revenue and Market Share by Country
8.1.1 South America IVIG Sales and Market Share by Country (2015-2020)
8.1.2 South America IVIG Revenue and Market Share by Country (2015-2020)
8.2 Brazil IVIG Sales and Growth Rate (2015-2020)
8.3 Argentina IVIG Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa IVIG Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa IVIG Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa IVIG Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia IVIG Sales and Growth Rate (2015-2020)
9.3 Turkey IVIG Sales and Growth Rate (2015-2020)
9.4 Egypt IVIG Sales and Growth Rate (2015-2020)
9.5 South Africa IVIG Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global IVIG Sales and Market Share by Type (2015-2020)
10.2 Global IVIG Revenue and Market Share by Type (2015-2020)
10.3 Global IVIG Price by Type (2015-2020)
11 Global IVIG Market Segment by Application
11.1 Global IVIG Sales Market Share by Application (2015-2020)
11.2 Global IVIG Revenue Market Share by Application (2015-2020)
11.3 Global IVIG Price by Application (2015-2020)
12 Market Forecast
12.1 Global IVIG Sales, Revenue and Growth Rate (2021-2025)
12.2 IVIG Market Forecast by Regions (2021-2025)
12.2.1 North America IVIG Market Forecast (2021-2025)
12.2.2 Europe IVIG Market Forecast (2021-2025)
12.2.3 Asia-Pacific IVIG Market Forecast (2021-2025)
12.2.4 South America IVIG Market Forecast (2021-2025)
12.2.5 Middle East & Africa IVIG Market Forecast (2021-2025)
12.3 IVIG Market Forecast by Type (2021-2025)
12.3.1 Global IVIG Sales Forecast by Type (2021-2025)
12.3.2 Global IVIG Market Share Forecast by Type (2021-2025)
12.4 IVIG Market Forecast by Application (2021-2025)
12.4.1 Global IVIG Sales Forecast by Application (2021-2025)
12.4.2 Global IVIG Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global IVIG Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of IVIG by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global IVIG Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Green Cross Basic Information, Manufacturing Base and Competitors
Table 8. Green Cross IVIG Major Business
Table 9. Green Cross IVIG Total Revenue (USD Million) (2017-2018)
Table 10. Green Cross SWOT Analysis
Table 11. Green Cross IVIG Product and Services
Table 12. Green Cross IVIG Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Taibang Bio Basic Information, Manufacturing Base and Competitors
Table 14. Taibang Bio IVIG Major Business
Table 15. Taibang Bio IVIG Total Revenue (USD Million) (2017-2018)
Table 16. Taibang Bio SWOT Analysis
Table 17. Taibang Bio IVIG Product and Services
Table 18. Taibang Bio IVIG Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. RAAS Basic Information, Manufacturing Base and Competitors
Table 20. RAAS IVIG Major Business
Table 21. RAAS IVIG Total Revenue (USD Million) (2017-2018)
Table 22. RAAS SWOT Analysis
Table 23. RAAS IVIG Product and Services
Table 24. RAAS IVIG Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. BSV Basic Information, Manufacturing Base and Competitors
Table 26. BSV IVIG Major Business
Table 27. BSV IVIG Total Revenue (USD Million) (2017-2018)
Table 28. BSV SWOT Analysis
Table 29. BSV IVIG Product and Services
Table 30. BSV IVIG Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Tiantan Bio Basic Information, Manufacturing Base and Competitors
Table 32. Tiantan Bio IVIG Major Business
Table 33. Tiantan Bio IVIG Total Revenue (USD Million) (2017-2018)
Table 34. Tiantan Bio SWOT Analysis
Table 35. Tiantan Bio IVIG Product and Services
Table 36. Tiantan Bio IVIG Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 38. Hualan Bio IVIG Major Business
Table 39. Hualan Bio IVIG Total Revenue (USD Million) (2017-2018)
Table 40. Hualan Bio SWOT Analysis
Table 41. Hualan Bio IVIG Product and Services
Table 42. Hualan Bio IVIG Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. SIBP Basic Information, Manufacturing Base and Competitors
Table 44. SIBP IVIG Major Business
Table 45. SIBP IVIG Total Revenue (USD Million) (2017-2018)
Table 46. SIBP SWOT Analysis
Table 47. SIBP IVIG Product and Services
Table 48. SIBP IVIG Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Kangbao Bio Basic Information, Manufacturing Base and Competitors
Table 50. Kangbao Bio IVIG Major Business
Table 51. Kangbao Bio IVIG Total Revenue (USD Million) (2017-2018)
Table 52. Kangbao Bio SWOT Analysis
Table 53. Kangbao Bio IVIG Product and Services
Table 54. Kangbao Bio IVIG Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. YUAN DA SHUYANG Basic Information, Manufacturing Base and Competitors
Table 56. YUAN DA SHUYANG IVIG Major Business
Table 57. YUAN DA SHUYANG IVIG Total Revenue (USD Million) (2017-2018)
Table 58. YUAN DA SHUYANG SWOT Analysis
Table 59. YUAN DA SHUYANG IVIG Product and Services
Table 60. YUAN DA SHUYANG IVIG Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Weiguang Bio Basic Information, Manufacturing Base and Competitors
Table 62. Weiguang Bio IVIG Major Business
Table 63. Weiguang Bio IVIG Total Revenue (USD Million) (2017-2018)
Table 64. Weiguang Bio SWOT Analysis
Table 65. Weiguang Bio IVIG Product and Services
Table 66. Weiguang Bio IVIG Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Xinxing Medicine Basic Information, Manufacturing Base and Competitors
Table 68. Xinxing Medicine IVIG Major Business
Table 69. Xinxing Medicine IVIG Total Revenue (USD Million) (2017-2018)
Table 70. Xinxing Medicine SWOT Analysis
Table 71. Xinxing Medicine IVIG Product and Services
Table 72. Xinxing Medicine IVIG Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. TONROL Basic Information, Manufacturing Base and Competitors
Table 74. TONROL IVIG Major Business
Table 75. TONROL IVIG Total Revenue (USD Million) (2017-2018)
Table 76. TONROL SWOT Analysis
Table 77. TONROL IVIG Product and Services
Table 78. TONROL IVIG Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Weilun Bio Basic Information, Manufacturing Base and Competitors
Table 80. Weilun Bio IVIG Major Business
Table 81. Weilun Bio IVIG Total Revenue (USD Million) (2017-2018)
Table 82. Weilun Bio SWOT Analysis
Table 83. Weilun Bio IVIG Product and Services
Table 84. Weilun Bio IVIG Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. RUIDE Bio Basic Information, Manufacturing Base and Competitors
Table 86. RUIDE Bio IVIG Major Business
Table 87. RUIDE Bio IVIG Total Revenue (USD Million) (2017-2018)
Table 88. RUIDE Bio SWOT Analysis
Table 89. RUIDE Bio IVIG Product and Services
Table 90. RUIDE Bio IVIG Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. RUIDE Bio Basic Information, Manufacturing Base and Competitors
Table 92. RUIDE Bio IVIG Major Business
Table 93. RUIDE Bio IVIG Total Revenue (USD Million) (2017-2018)
Table 94. RUIDE Bio SWOT Analysis
Table 95. RUIDE Bio IVIG Product and Services
Table 96. RUIDE Bio IVIG Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. WIBP Basic Information, Manufacturing Base and Competitors
Table 98. WIBP IVIG Major Business
Table 99. WIBP IVIG Total Revenue (USD Million) (2017-2018)
Table 100. WIBP SWOT Analysis
Table 101. WIBP IVIG Product and Services
Table 102. WIBP IVIG Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. BOYA Bio Basic Information, Manufacturing Base and Competitors
Table 104. BOYA Bio IVIG Major Business
Table 105. BOYA Bio IVIG Total Revenue (USD Million) (2017-2018)
Table 106. BOYA Bio SWOT Analysis
Table 107. BOYA Bio IVIG Product and Services
Table 108. BOYA Bio IVIG Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 109. Global IVIG Sales by Manufacturer (2018-2019) (K Units)
Table 110. Global IVIG Revenue by Manufacturer (2018-2019) (USD Million)
Table 111. Global IVIG Sales by Regions (2015-2020) (K Units)
Table 112. Global IVIG Sales Market Share by Regions (2015-2020)
Table 113. Global IVIG Revenue by Regions (2015-2020) (USD Million)
Table 114. North America IVIG Sales by Countries (2015-2020) (K Units)
Table 115. North America IVIG Sales Market Share by Countries (2015-2020)
Table 116. North America IVIG Revenue by Countries (2015-2020) (USD Million)
Table 117. North America IVIG Revenue Market Share by Countries (2015-2020)
Table 118. Europe IVIG Sales by Countries (2015-2020) (K Units)
Table 119. Europe IVIG Sales Market Share by Countries (2015-2020)
Table 120. Europe IVIG Revenue by Countries (2015-2020) (USD Million)
Table 121. Asia-Pacific IVIG Sales by Regions (2015-2020) (K Units)
Table 122. Asia-Pacific IVIG Sales Market Share by Regions (2015-2020)
Table 123. Asia-Pacific IVIG Revenue by Regions (2015-2020) (USD Million)
Table 124. South America IVIG Sales by Countries (2015-2020) (K Units)
Table 125. South America IVIG Sales Market Share by Countries (2015-2020)
Table 126. South America IVIG Revenue by Countries (2015-2020) (USD Million)
Table 127. South America IVIG Revenue Market Share by Countries (2015-2020)
Table 128. Middle East & Africa IVIG Sales by Countries (2015-2020) (K Units)
Table 129. Middle East & Africa IVIG Sales Market Share by Countries (2015-2020)
Table 130. Middle East & Africa IVIG Revenue by Countries (2015-2020) (USD Million)
Table 131. Middle East & Africa IVIG Revenue Market Share by Countries (2015-2020)
Table 132. Global IVIG Sales by Type (2015-2020) (K Units)
Table 133. Global IVIG Sales Share by Type (2015-2020)
Table 134. Global IVIG Revenue by Type (2015-2020) (USD Million)
Table 135. Global IVIG Revenue Share by Type (2015-2020)
Table 136. Global IVIG Sales by Application (2015-2020) (K Units)
Table 137. Global IVIG Sales Share by Application (2015-2020)
Table 138. Global IVIG Sales Forecast by Regions (2021-2025) (K Units)
Table 139. Global IVIG Market Share Forecast by Regions (2021-2025)
Table 140. Global IVIG Sales Forecast by Type (2021-2025) (K Units)
Table 141. Global IVIG Market Share Forecast by Type (2021-2025)
Table 142. Global IVIG Sales Forecast by Application (2021-2025)
Table 143. Global IVIG Market Share Forecast by Application (2021-2025)
Table 144. Direct Channel Pros & Cons
Table 145. Indirect Channel Pros & Cons
Table 146. Distributors/Traders/ Dealers List
List of Figures
Figure 1. IVIG Picture
Figure 2. Global Sales Market Share of IVIG by Type in 2019
Figure 3. Injection Picture
Figure 4. Lyophilized Powder Picture
Figure 5. IVIG Sales Market Share by Application in 2018
Figure 6. Multiple Sclerosis (MS) Picture
Figure 7. Myasthenia Gravis (MG) Picture
Figure 8. Multifocal Motor Neuropathy (MMN) Picture
Figure 9. Multifocal Acquired Sensory and Motor Neuropathy (MADSAM) Picture
Figure 10. Dermatomyositis Picture
Figure 11. Polymyositis Picture
Figure 12. Global IVIG Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States IVIG Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada IVIG Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico IVIG Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany IVIG Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France IVIG Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK IVIG Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia IVIG Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy IVIG Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China IVIG Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan IVIG Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea IVIG Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India IVIG Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia IVIG Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia IVIG Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil IVIG Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt IVIG Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia IVIG Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa IVIG Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey IVIG Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global IVIG Sales Market Share by Manufacturer in 2019
Figure 33. Global IVIG Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 IVIG Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 IVIG Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global IVIG Sales and Growth Rate (2015-2020) (K Units)
Figure 38. Global IVIG Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global IVIG Revenue Market Share by Regions (2015-2020)
Figure 40. Global IVIG Revenue Market Share by Regions in 2018
Figure 41. North America IVIG Sales and Growth Rate (2015-2020)
Figure 42. Europe IVIG Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific IVIG Sales and Growth Rate (2015-2020)
Figure 44. South America IVIG Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa IVIG Sales and Growth Rate (2015-2020)
Figure 46. North America IVIG Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America IVIG Sales Market Share by Countries (2015-2020)
Figure 48. North America IVIG Sales Market Share by Countries in 2018
Figure 49. North America IVIG Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America IVIG Revenue Market Share by Countries in 2018
Figure 51. United States IVIG Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Canada IVIG Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Mexico IVIG Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Europe IVIG Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe IVIG Revenue Market Share by Countries (2015-2020)
Figure 56. Europe IVIG Revenue Market Share by Countries in 2019
Figure 57. Germany IVIG Sales and Growth Rate (2015-2020) (K Units)
Figure 58. UK IVIG Sales and Growth Rate (2015-2020) (K Units)
Figure 59. France IVIG Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Russia IVIG Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Italy IVIG Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Asia-Pacific IVIG Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific IVIG Sales Market Share by Regions 2019
Figure 64. Asia-Pacific IVIG Revenue Market Share by Regions 2019
Figure 65. China IVIG Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Japan IVIG Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Korea IVIG Sales and Growth Rate (2015-2020) (K Units)
Figure 68. India IVIG Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Southeast Asia IVIG Sales and Growth Rate (2015-2020) (K Units)
Figure 70. South America IVIG Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America IVIG Sales Market Share by Countries in 2019
Figure 72. South America IVIG Revenue Market Share by Countries in 2019
Figure 73. Brazil IVIG Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Argentina IVIG Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Middle East and Africa IVIG Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa IVIG Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa IVIG Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa IVIG Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia IVIG Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Egypt IVIG Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Turkey IVIG Sales and Growth Rate (2015-2020) (K Units)
Figure 82. South Africa IVIG Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Global IVIG Sales and Growth Rate (2021-2025) (K Units)
Figure 84. Global IVIG Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales IVIG Market Forecast (2021-2025) (K Units)
Figure 86. Europe Sales IVIG Market Forecast (2021-2025) (K Units)
Figure 87. Asia-Pacific Sales IVIG Market Forecast (2021-2025) (K Units)
Figure 88. South America Sales IVIG Market Forecast (2021-2025) (K Units)
Figure 89. Middle East & Africa Sales IVIG Market Forecast (2021-2025) (K Units)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
IVIGの世界市場（～2026年） Market Analysis and Insights: Global IVIG Market The global IVIG market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global IVIG Scope and Market Size IVIG market is segmented by Type, and by Application. Players, stakeholders, a…- 凍結乾燥IVIGの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Lyophilized IVIG market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Lyophilized IVIG market repo…
- IVIgリキッドの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global IVIg Liquid market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The IVIg Liquid market report provide…
- 重症筋無力症の世界市場（～2026年） Myasthenia gravis (MG) is a long-term neuromuscular disease that leads to varying degrees of skeletal muscle weakness. The most commonly affected muscles are those of the eyes, face, and swallowing. It can result in double vision, drooping eyelids, trouble talking, and trouble walking. Onset can be …
- 重症筋無力症治療薬の世界市場（～2026年） Myasthenia gravis is a neuromuscular disorder that leads to the weakening of skeletal muscles, which are responsible for the movement of the body. This condition occurs due to the impairment of communication between muscles and nerve cells. This impairment causes difficulties in the contraction and …